Sorin Group

Developer of technologies or cardiac surgery reports on stockholders meeting

Published in Cardiovascular Business Week, June 28th, 2005

The Stockholders' meeting of Sorin S.p.A., convened in Milan, Italy, under the chairmanship of Umberto Rosa and attended by stockholders representing 57.9% of the capital stock, reviewed and approved the Annual Report at December 31, 2004.

In 2004, the group reported revenues of EUR721.3 million (US$765.1 million). A breakdown by business unit is as follows: 58%, or EUR416.1 million (US$504.8 million) for cardiac surgery; 24%, or EUR175.1 million, (US$212.4 million) for cardiac rhythm management; 3%, or EUR23.8 million, (US$28.9 million) for vascular therapy and new businesses; and 15%, or EUR105.7 million, (US$128.2 million) for renal care.

The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week

Source: Cardiovascular Business Week (2005-06-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry